Big Pharma's Stock Spending Exceeds R&D, Dems Say
Major pharmaceutical companies spent nearly $600 billion to inflate their stock prices and reward shareholders in recent years, easily outpacing their spending on drug development, House Democrats said in a new...To view the full article, register now.
Already a subscriber? Click here to view full article